Journal of Clinical Toxicology
Open Access

William J Ehlhardt

Biography

Dr.William J Ehlhardt Works as a Senior Research Scientist Drug Met at Eli Lilly and Company. He has contributed his work on Nonclinical Safety Evaluation of a Transforming Growth Factor β Receptor I Kinase Inhibitor in Fischer 344 Rats and Beagle Dogs in the Journal of Clinical Toxicology

Research Interest

TGF-β Inhibitor, Kinase, Drug-associated cardiovascular toxicity, Rats, Dogs, Toxicology, Pathology

Relevant Topics